Clinical Trials List
Protocol NumberAWT-EXK21-001
2022-01-01 - 2024-08-08
Phase I
Recruiting1
Terminated2
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Tzu-Yao Liao Division of Hematology & Oncology
- Ming-Hung Hu Division of Hematology & Oncology
- Chia-Lun Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Yu Hsieh Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tsung -Chih Chen Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
0 participants
